Tag
Pharmacogenomics
118 genetic variants with this tag.
| RSID | Gene | Description | Category | ||
|---|---|---|---|---|---|
| rs1000940 | RABEP1 RABEP1 Metabolic-Immune Regulatory Variant | Intronic variant in RABEP1 associated with fasting glucose modulation under p... | Autoimmune Tolerance & T-Cell Regulation | Emerging | |
| rs1008899 | NEDD4L | Intronic NEDD4L variant tagging isoforms with differing ENaC ubiquitination c... | Blood Pressure & Hypertension | Moderate | |
| rs10305420 | GLP1R Pro7Leu | GLP-1 receptor signal peptide variant that enhances semaglutide and tirzepati... | Pharmacogenomics | Moderate | |
| rs10509679 | CYP2C9 | Intronic CYP2C9 haplotype tag associated with increased ischemic stroke risk ... | Coronary Artery Disease & Atherosclerosis | Emerging | |
| rs10305492 | GLP1R A316T | Rare protective missense variant in the GLP-1 receptor associated with lower ... | Pharmacogenomics | Strong | |
| rs10403955 | CYP2B6 | Intronic CYP2B6 haplotype-tagging variant associated with altered plasma conc... | Pharmacogenomics | Moderate | |
| rs11854484 | SLC28A2 SLC28A2 Pro22Leu | Missense variant in the concentrative nucleoside transporter 2 (CNT2) gene th... | Vitamins & Nutrient Absorption | Moderate | |
| rs1042044 | GLP1R Leu260Phe | GLP-1 receptor variant in intracellular loop 2 that alters receptor surface e... | Pharmacogenomics | Moderate | |
| rs12188300 | IL12B | Near-gene variant at the IL12B locus associated with psoriasis risk through a... | Psoriasis & Spondyloarthropathy | Moderate | |
| rs1045642 | ABCB1 C3435T | Synonymous variant in P-glycoprotein affecting drug efflux pump expression an... | Pharmacogenomics | Moderate | |
| rs1805123 | KCNH2 K897T | Common KCNH2 missense variant that alters hERG potassium channel kinetics, sh... | Arrhythmia & Heart Rhythm | Strong | |
| rs199473521 | KCNH2 K595N | Ultra-rare KCNH2 missense variant substituting asparagine for lysine at posit... | Arrhythmia & Heart Rhythm | Moderate | |
| rs1058164 | CYP2D6 | Synonymous CYP2D6 variant that promotes exon 3 skipping, reducing functional ... | Pharmacogenomics | Moderate | |
| rs1058932 | CYP2C8 | CYP2C8 3-prime UTR variant associated with cardiovascular risk via altered ep... | Pharmacogenomics | Moderate | |
| rs1800975 | XPA A23G | 5' UTR variant in the XPA DNA damage recognition gene that modulates nucleoti... | Cancer Risk | Strong | |
| rs2032582 | ABCB1 G2677T/A (Ser893Ala/Thr) | Triallelic missense variant in the P-glycoprotein efflux pump that reduces th... | Gamete Quality & DNA Repair | Moderate | |
| rs11572325 | CYP2J2 | Intronic CYP2J2 variant associated with increased myocardial infarction risk ... | Vascular Inflammation & Remodeling | Moderate | |
| rs28937317 | SCN5A N1325S | Rare gain-of-function missense variant in the cardiac sodium channel Nav1.5 c... | Arrhythmia & Heart Rhythm | Established | |
| rs1080985 | CYP2D6 *2A promoter | CYP2D6 promoter variant (-1584C>G) that reduces enzyme expression; the C alle... | Pharmacogenomics | Strong | |
| rs1113129 | CYP2C8 | Intronic tagging SNP for CYP2C8 haplotype C, a low-activity haplotype associa... | Pharmacogenomics | Moderate | |
| rs1142345 | TPMT *3C | No-function variant causing deficient thiopurine methylation; most common TPM... | Pharmacogenomics | Established | |
| rs116855232 | NUDT15 Arg139Cys | Nucleotide diphosphatase that inactivates toxic thiopurine metabolites; reduc... | Pharmacogenomics | Established | |
| rs2968864 | KCNH2 KCNH2 QT interval GWAS variant (7q36.1) | Intergenic variant at 7q36.1 near KCNH2 (hERG potassium channel) that modulat... | Arrhythmia & Heart Rhythm | Strong | |
| rs2317676 | ITGB3 | 3' UTR variant in the platelet glycoprotein IIIa gene (ITGB3/GPIIIa) that dis... | Von Willebrand & Anticoagulant Proteins | Moderate | |
| rs12721627 | CYP3A4 *16 | Missense variant reducing CYP3A4 enzyme activity by 50–74% depending on subst... | Pharmacogenomics | Moderate | |
| rs12721629 | CYP3A4 *16B | Missense variant causing substrate-dependent reduced CYP3A4 activity, most pr... | Pharmacogenomics | Moderate | |
| rs2293275 | LHCGR Asn312Ser (N312S) | Affects LH/hCG receptor sensitivity near a glycosylation site, influencing ov... | Fertility & Ovarian Function | Strong | |
| rs1341162 | CYP2C8 | Intronic CYP2C8 haplotype-tagging variant linked to altered drug metabolism c... | Pharmacogenomics | Moderate | |
| rs20455 | KIF6 Trp719Arg | Missense variant in kinesin family member 6; the Arg allele was associated wi... | Coronary Artery Disease & Atherosclerosis | Moderate | |
| rs1341164 | CYP2C8 | Intronic CYP2C8 variant tagging a haplotype associated with altered taxane dr... | Pharmacogenomics | Emerging | |
| rs2413775 | SLC28A2 | Promoter variant that increases SLC28A2/CNT2 transcription via enhanced HNF1 ... | Vitamins & Nutrient Absorption | Emerging | |
| rs5925 | LDLR LDLR Expression Co-variant | Synonymous variant in LDLR exon 13 that modulates mRNA splicing efficiency in... | Atherogenic Lipoproteins | Moderate | |
| rs16947 | CYP2D6 *2 | Common CYP2D6 variant defining the *2 allele; previously considered normal-fu... | Pharmacogenomics | Strong | |
| rs6008845 | PPARA PPARA intronic C/T | Regulatory PPARA variant where TT homozygotes with type 2 diabetes experience... | Atherogenic Lipoproteins | Strong | |
| rs17002852 | CYP2D6 | Synonymous CYP2D6 variant that causes allele dropout in standard CYP2D6*3 gen... | Pharmacogenomics | Moderate | |
| rs6511720 | LDLR Intron 1 | Common regulatory variant in the LDL receptor gene affecting LDLR expression,... | Atherogenic Lipoproteins | Strong | |
| rs1799971 | OPRM1 A118G | Mu-opioid receptor variant affecting opioid response, pain sensitivity, and p... | Pharmacogenomics | Strong | |
| rs25531 | SLC6A4 A>G | Promoter SNP near 5-HTTLPR that modifies serotonin transporter expression and... | Mood & Behavior | Moderate | |
| rs1800460 | TPMT *3B | Decreased-function variant causing reduced thiopurine methylation; pairs with... | Pharmacogenomics | Established | |
| rs1800462 | TPMT *2 | The original TPMT deficiency allele — a no-function star allele causing ~100-... | Pharmacogenomics | Established | |
| rs1801272 | CYP2A6 *2 (L160H) | Loss-of-function CYP2A6 variant that abolishes nicotine metabolism, slowing c... | Pharmacogenomics | Established | |
| rs489693 | MC4R MC4R AIWG variant | Intergenic variant near MC4R with genome-wide significant association with an... | Appetite & Obesity | Strong | |
| rs1934951 | CYP2C8 | Intronic CYP2C8 variant associated with paclitaxel-induced toxicity and bisph... | Pharmacogenomics | Moderate | |
| rs72551348 | UGT1A1 Q331R | Rare pathogenic missense variant in the UGT1A1 gene that severely reduces bil... | Uric Acid & Kidney Function | Strong | |
| rs1934953 | CYP2C8 | Intronic CYP2C8 variant linked to epoxygenase pathway activity, hypertension ... | Pharmacogenomics | Emerging | |
| rs396991 | FCGR3A V158F | Missense variant in Fc gamma receptor IIIa (CD16a) that determines NK cell Ig... | Innate Immunity & Infection Defense | Strong | |
| rs1934963 | CYP2C9 | Deep intronic CYP2C9 variant associated with altered drug response to sulfony... | Pharmacogenomics | Emerging | |
| rs1934967 | CYP2C9 | Intronic CYP2C9 haplotype tag associated with altered warfarin sensitivity an... | Pharmacogenomics | Moderate | |
| rs3846662 | HMGCR HMGCR Intron 13 Splice Variant | Intronic HMGCR variant that modulates alternative splicing of exon 13, produc... | Cholesterol & Lipoproteins | Moderate | |
| rs1934980 | CYP2C8 | Intronic CYP2C8 variant linked to altered enzyme expression and associated wi... | Pharmacogenomics | Moderate | |
| rs3846663 | HMGCR HMGCR Exon 13 Haplotype Tag | Intronic HMGCR variant that tags a haplotype influencing exon 13 alternative ... | Cholesterol & Lipoproteins | Strong | |
| rs2069526 | CYP1A2 -739T>G | Intronic CYP1A2 variant near the 5' end; G allele is associated with altered ... | Pharmacogenomics | Emerging | |
| rs2070672 | CYP2E1 | CYP2E1 promoter variant affecting enzyme expression and susceptibility to ace... | Pharmacogenomics | Moderate | |
| rs2070676 | CYP2E1 | Intronic CYP2E1 variant tagging the *1B haplotype; C allele marks reduced CYP... | Pharmacogenomics | Moderate | |
| rs6295 | HTR1A C-1019G | Functional promoter variant in the serotonin 1A receptor gene that increases ... | Mood & Behavior | Strong | |
| rs2242480 | CYP3A4 *1G | Intronic variant in CYP3A4 intron 10 that upregulates a suppressive lncRNA, r... | Pharmacogenomics | Strong | |
| rs2246709 | CYP3A4 | Intronic CYP3A4 variant associated with altered drug clearance, affecting met... | Pharmacogenomics | Moderate | |
| rs2280275 | CYP2J2 | Intronic variant in CYP2J2 that tags reduced epoxyeicosatrienoic acid (EET) p... | Pharmacogenomics | Moderate | |
| rs2289669 | SLC47A1 MATE1 G-1853A | Intronic variant in MATE1, the renal and hepatic metformin efflux transporter... | Pharmacogenomics | Moderate | |
| rs2480256 | CYP2E1 | 3' UTR variant that increases CYP2E1 expression, raising hepatotoxicity risk ... | Pharmacogenomics | Moderate | |
| rs8087522 | MC4R MC4R A/G (rs8087522) | Upstream regulatory variant near MC4R that may create a transcription factor ... | Appetite & Obesity | Emerging | |
| rs2515641 | CYP2E1 | Synonymous exon-8 variant that reduces CYP2E1 mRNA and protein expression, al... | Pharmacogenomics | Moderate | |
| rs887829 | UGT1A1 UGT1A1*80 | Promoter variant in UGT1A1 that tags the *28 reduced-expression haplotype; T ... | Vascular Inflammation & Remodeling | Strong | |
| rs2740574 | CYP3A4 *1B -392A>G | Promoter variant affecting CYP3A4 expression, most common in African populations | Pharmacogenomics | Moderate | |
| rs63749869 | RYR1 R4861H (Arg4861His) | RYR1 missense variant causing malignant hyperthermia susceptibility and centr... | Fitness & Body | Established | |
| rs28371706 | CYP2D6 *17 | Decreased-function CYP2D6 allele common in African populations, reducing meta... | Pharmacogenomics | Established | |
| rs78707713 | TSPAN15 | Intronic TSPAN15 variant that modulates ADAM10-mediated shedding of GPVI, the... | Coronary Artery Disease & Atherosclerosis | Strong | |
| rs28371725 | CYP2D6 *41 | Intronic splice variant causing decreased CYP2D6 enzyme activity through aber... | Pharmacogenomics | Established | |
| rs28371733 | CYP2D6 | Rare CYP2D6 stop-gain variant (Glu418Ter) that eliminates enzyme activity, ca... | Pharmacogenomics | Established | |
| rs28371759 | CYP3A4 *18 (L293R) | Rare missense variant causing a Leu293Arg substitution in CYP3A4, associated ... | Pharmacogenomics | Moderate | |
| rs28399433 | CYP2A6 *9 (TATA box) | Promoter variant that reduces CYP2A6 expression by ~50%, slowing nicotine met... | Pharmacogenomics | Strong | |
| rs28399444 | CYP2A6 *7 (I471T) | CYP2A6*7 missense variant that nearly abolishes nicotine C-oxidase activity; ... | Pharmacogenomics | Established | |
| rs28695233 | CYP2D6 | Deep intronic CYP2D6 variant in intron 2 that serves as a haplotype tag in sp... | Pharmacogenomics | Emerging | |
| rs2653349 | HCRTR2 Ile308Val | Missense variant at position 308 of the orexin receptor 2 protein; the minor ... | Neurology & Cognition | Strong | |
| rs316019 | SLC22A2 Ala270Ser | Reduces OCT2 organic cation transporter function in the kidney, lowering metf... | Pharmacogenomics | Moderate | |
| rs35599367 | CYP3A4 *22 | Intronic splice variant causing ~50% reduced CYP3A4 mRNA expression, affectin... | Pharmacogenomics | Established | |
| rs368234815 | IFNL4 ss469415590 (TT/ΔG) | Causal frameshift polymorphism controlling IFNL4 protein production; the ΔG a... | Pharmacogenomics | Established | |
| rs373489637 | CYP2B6 V183G | Near-complete loss-of-function CYP2B6 variant causing severely impaired metab... | Pharmacogenomics | Moderate | |
| rs3758581 | CYP2C19 Ile331Val (CYP2C19*1B) | Common CYP2C19 missense variant defining the *1B allele; the G (Val331) allel... | Pharmacogenomics | Moderate | |
| rs3765467 | GLP1R Arg131Gln | Missense variant in the GLP-1 receptor that alters drug response to GLP-1 ago... | Pharmacogenomics | Moderate | |
| rs3788189 | SLC19A1 SLC19A1 IVS2 variant | Intronic variant in the folate transporter gene associated with pemetrexed tr... | Methylation & Detox | Emerging | |
| rs3791033 | KDM4A | Intronic variant in KDM4A histone demethylase associated with problematic opi... | Pharmacogenomics | Moderate | |
| rs3814637 | CYP2C19 | Upstream CYP2C19 variant associated with altered R-warfarin clearance and inc... | Pharmacogenomics | Moderate | |
| rs5030868 | G6PD G6PD Mediterranean | Severe Class II G6PD deficiency variant (c.563C>T, p.Ser188Phe) causing less ... | Blood Sugar & Diabetes | Established | |
| rs3918290 | DPYD *2A | Most critical pharmacogenomic variant causing complete loss of DPD enzyme fun... | Pharmacogenomics | Established | |
| rs5219 | KCNJ11 E23K | Controls the pancreatic beta-cell potassium channel that regulates insulin se... | Blood Sugar & Diabetes | Strong | |
| rs4148323 | UGT1A1 *6 Gly71Arg | Phase II glucuronidation enzyme that metabolizes bilirubin and many drugs inc... | Pharmacogenomics | Established | |
| rs6166 | FSHR Asn680Ser (N680S) | Affects FSH receptor sensitivity, determining ovarian response to FSH stimula... | Hormones & Sleep | Strong | |
| rs4684059 | HRH1 | Intronic variant in the histamine H1 receptor gene associated with altered re... | Methylation & Detox | Emerging | |
| rs4646438 | CYP3A4 *6 (17776insA / frameshift) | Frameshift insertion in CYP3A4 exon 9 that produces a truncated, non-function... | Pharmacogenomics | Strong | |
| rs4646976 | CYP2E1 | CYP2E1 intronic haplotype tag — affects enzyme activity and susceptibility to... | Pharmacogenomics | Moderate | |
| rs4997557 | CYP2A6 | Rare CYP2A6 missense variant (p.Thr294Ile) that likely reduces nicotine-metab... | Pharmacogenomics | Emerging | |
| rs5030655 | CYP2D6 *6 | Frameshift deletion causing no enzyme function, defining poor metabolizer sta... | Pharmacogenomics | Established | |
| rs55785340 | CYP3A4 *2 | Missense variant reducing CYP3A4-mediated nifedipine clearance, causing eleva... | Pharmacogenomics | Moderate | |
| rs55886062 | DPYD *13 | No-function DPYD star allele (I560S) causing severe DPD deficiency; one of fo... | Pharmacogenomics | Established | |
| rs55897648 | CYP2E1 *3 (Val389Ile) | CYP2E1*3 missense variant with no demonstrated change in enzyme activity for ... | Pharmacogenomics | Emerging | |
| rs7202877 | CTRB1 | Intergenic variant near CTRB1/CTRB2 that regulates chymotrypsinogen expressio... | Blood Sugar & Diabetes | Strong | |
| rs56038477 | DPYD HapB3 tag (c.1236G>A, E412E) | Synonymous exon-11 tag SNP for the DPYD HapB3 haplotype; benign on its own bu... | Pharmacogenomics | Established | |
| rs76723693 | G6PD G6PD Nefza (c.968T>C) | Missense variant in glucose-6-phosphate dehydrogenase causing Class III G6PD ... | Blood Sugar & Diabetes | Strong | |
| rs58194899 | EIPR1 | Intronic variant in EIPR1 (endosomal trafficking protein) associated with pai... | Pharmacogenomics | Emerging | |
| rs58440431 | CYP2D6 | Intronic CYP2D6 variant tagging East Asian *10-lineage suballeles; the C alle... | Pharmacogenomics | Strong | |
| rs622342 | SLC22A1 A>C | Intronic variant in the OCT1 organic cation transporter reducing hepatic metf... | Pharmacogenomics | Moderate | |
| rs640561 | LRRIQ3 | Intergenic variant near LRRIQ3 associated with problematic opioid prescriptio... | Pharmacogenomics | Emerging | |
| rs6413419 | CYP2E1 *4 (V179I) | Missense variant (Val179Ile) defining the CYP2E1*4 allele; associated with al... | Pharmacogenomics | Emerging | |
| rs67376798 | DPYD D949V | Decreased-function variant reducing DPD enzyme activity ~30%, requiring 50% f... | Pharmacogenomics | Established | |
| rs67784355 | CYP3A4 *11 (Thr363Met) | Rare missense variant in CYP3A4 that reduces protein expression and enzymatic... | Pharmacogenomics | Emerging | |
| rs67807361 | CYP2C9 p.Leu19Ile | Rare CYP2C9 N-terminal missense variant of uncertain functional significance ... | Pharmacogenomics | Emerging | |
| rs6923761 | GLP1R Gly168Ser | GLP-1 receptor variant that alters response to GLP-1 agonist medications used... | Pharmacogenomics | Moderate | |
| rs71328650 | CYP2D6 | Intronic CYP2D6 haplotype tag variant (rs28371702 canonical form) associated ... | Pharmacogenomics | Emerging | |
| rs72547511 | CYP1A2 CYP1A2*15 (Pro42Arg) | Rare CYP1A2 missense variant at the critical Pro42 position; nearly abolishes... | Pharmacogenomics | Moderate | |
| rs72547515 | CYP1A2 *16 (Arg377Gln) | Nearly-inactive CYP1A2 missense variant — carriers have severely impaired met... | Pharmacogenomics | Moderate | |
| rs6795209 | HTR1F | Intergenic variant at the HTR1F locus on chromosome 3; the minor A allele inc... | Neurology & Cognition | Strong | |
| rs72547516 | CYP1A2 Ile386Val | Rare CYP1A2 missense variant (Ile386Val) associated with potentially reduced ... | Pharmacogenomics | Emerging | |
| rs72547517 | CYP1A2 *8 | CYP1A2*8 — near-complete loss-of-function missense variant causing severely r... | Pharmacogenomics | Strong | |
| rs72549354 | CYP2D6 *20 | Frameshift insertion creating a null CYP2D6 allele; carriers cannot metaboliz... | Pharmacogenomics | Established | |
| rs75017182 | DPYD HapB3 (c.1129-5923C>G) | Deep intronic splice-site variant that is the functional driver of the DPYD H... | Pharmacogenomics | Established | |
| rs776746 | CYP3A5 *3 | Splice site variant creating a non-functional CYP3A5 enzyme, dramatically aff... | Pharmacogenomics | Established | |
| rs8192780 | CYP2E1 | Downstream regulatory variant near CYP2E1 associated with nasopharyngeal carc... | Pharmacogenomics | Emerging |